These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34747281)

  • 1. Assessing effect heterogeneity of a randomized treatment using conditional inference trees.
    Venkatasubramaniam A; Koch B; Erickson L; French S; Vock D; Wolfson J
    Stat Methods Med Res; 2022 Mar; 31(3):549-562. PubMed ID: 34747281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate.
    Wolf JM; Koopmeiners JS; Vock DM
    Clin Trials; 2022 Oct; 19(5):512-521. PubMed ID: 35531765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision trees in epidemiological research.
    Venkatasubramaniam A; Wolfson J; Mitchell N; Barnes T; JaKa M; French S
    Emerg Themes Epidemiol; 2017; 14():11. PubMed ID: 28943885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect.
    Shen C; Jeong J; Li X; Chen PS; Buxton A
    Biometrics; 2013 Sep; 69(3):724-31. PubMed ID: 23865447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing methods for estimation of heterogeneous treatment effects using observational data from health care databases.
    Wendling T; Jung K; Callahan A; Schuler A; Shah NH; Gallego B
    Stat Med; 2018 Oct; 37(23):3309-3324. PubMed ID: 29862536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining heterogeneity of individual treatment causal effects by subgroup discovery: An observational case study in antibiotics treatment of acute rhino-sinusitis.
    Qi W; Abu-Hanna A; van Esch TEM; de Beurs D; Liu Y; Flinterman LE; Schut MC
    Artif Intell Med; 2021 Jun; 116():102080. PubMed ID: 34020753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A BAYESIAN MACHINE LEARNING APPROACH FOR ESTIMATING HETEROGENEOUS SURVIVOR CAUSAL EFFECTS: APPLICATIONS TO A CRITICAL CARE TRIAL.
    Chen X; Harhay MO; Tong G; Li F
    Ann Appl Stat; 2024 Mar; 18(1):350-374. PubMed ID: 38455841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference for the treatment effect in longitudinal cluster randomized trials when treatment effect heterogeneity is ignored.
    Bowden R; Forbes AB; Kasza J
    Stat Methods Med Res; 2021 Nov; 30(11):2503-2525. PubMed ID: 34569853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Flexible Approach for Assessing Heterogeneity of Causal Treatment Effects on Patient Survival Using Large Datasets with Clustered Observations.
    Hu L; Ji J; Liu H; Ennis R
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Heterogeneity of Treatment Effects in Observational Studies.
    Robertson SE; Leith A; Schmid CH; Dahabreh IJ
    Am J Epidemiol; 2021 Jun; 190(6):1088-1100. PubMed ID: 33083822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSICA: Decision trees for probabilistic subgroup identification with categorical treatments.
    Sysoev O; Bartoszek K; Ekström EC; Ekholm Selling K
    Stat Med; 2019 Sep; 38(22):4436-4452. PubMed ID: 31246349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction error.
    Meyvisch P; Alonso A; Van der Elst W; Molenberghs G
    Pharm Stat; 2019 May; 18(3):304-315. PubMed ID: 30575256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quint: An R package for the identification of subgroups of clients who differ in which treatment alternative is best for them.
    Dusseldorp E; Doove L; Mechelen Iv
    Behav Res Methods; 2016 Jun; 48(2):650-63. PubMed ID: 26092391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal inference with measurement error in outcomes: Bias analysis and estimation methods.
    Shu D; Yi GY
    Stat Methods Med Res; 2019 Jul; 28(7):2049-2068. PubMed ID: 29241426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal inference in paired two-arm experimental studies under noncompliance with application to prognosis of myocardial infarction.
    Bartolucci F; Farcomeni A
    Stat Med; 2013 Nov; 32(25):4348-66. PubMed ID: 23754710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes.
    Yip WK; Bonetti M; Cole BF; Barcella W; Wang XV; Lazar A; Gelber RD
    Clin Trials; 2016 Aug; 13(4):382-90. PubMed ID: 27094489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome--a simulation study.
    Chu R; Walter SD; Guyatt G; Devereaux PJ; Walsh M; Thorlund K; Thabane L
    PLoS One; 2012; 7(5):e36677. PubMed ID: 22629322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing conditional causal effect via characteristic score.
    Hu Z
    Stat Med; 2021 Oct; 40(24):5188-5198. PubMed ID: 34181277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inference on covariate effect types for treatment effectiveness in a randomized trial with a binary outcome.
    Chiba Y
    Clin Trials; 2019 Jun; 16(3):237-245. PubMed ID: 30760066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.